Cytek Biosciences Inc (CTKB)
Net profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | -6,020 | -12,148 | 2,576 | 4,417 | 19,411 |
| Revenue | US$ in thousands | 200,453 | 193,015 | 164,036 | 127,950 | 92,839 |
| Net profit margin | -3.00% | -6.29% | 1.57% | 3.45% | 20.91% |
December 31, 2024 calculation
Net profit margin = Net income ÷ Revenue
= $-6,020K ÷ $200,453K
= -3.00%
Net profit margin is a key profitability ratio that indicates the percentage of revenue that translates into net profit after all expenses are deducted. Analyzing the net profit margin trend of Cytek Biosciences Inc from 2020 to 2024 reveals a significant decline.
In December 2020, the net profit margin stood at a healthy 20.91%, indicating that the company retained approximately 20.91% of its revenue as net profit. However, there was a notable decrease in profitability in the subsequent years.
By December 2021, the net profit margin dropped to 3.45%, reflecting a considerable decrease in profitability. This declining trend continued in the following years, with the net profit margin decreasing to 1.57% in December 2022, -6.29% in December 2023, and -3.00% in December 2024.
The decreasing trend in net profit margin from 2020 to 2024 suggests that Cytek Biosciences Inc may be facing challenges in controlling costs or generating sufficient revenue to maintain profitability. Further investigation into the company's cost structure, revenue streams, and overall financial performance is recommended to address and rectify the declining profitability trend.
Peer comparison
Dec 31, 2024